A randomized, double-blind, placebo-controlled trial of probiotics to reduce the severity of oral mucositis induced by chemoradiotherapy for patients with nasopharyngeal carcinoma. [electronic resource]
Producer: 20191230Description: 1081-1090 p. digitalISSN:- 1097-0142
- Adult
- Antineoplastic Agents -- adverse effects
- Bifidobacterium longum
- Chemoradiotherapy -- adverse effects
- Cisplatin -- adverse effects
- DNA, Bacterial -- analysis
- Double-Blind Method
- Enterococcus faecium
- Female
- Gastrointestinal Microbiome -- genetics
- High-Throughput Nucleotide Sequencing
- Humans
- Lactobacillus
- Male
- Middle Aged
- Nasopharyngeal Carcinoma -- therapy
- Nasopharyngeal Neoplasms -- therapy
- Probiotics -- therapeutic use
- Radiotherapy, Intensity-Modulated -- adverse effects
- Sequence Analysis, DNA
- Severity of Illness Index
- Stomatitis -- prevention & control
No physical items for this record
Publication Type: Journal Article; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.